THE METABOLISM AND EXCRETION OF PROCHLORAZ, AN IMIDAZOLE-BASED FUNGICIDE, IN THE RAT

被引:16
作者
NEEDHAM, D
CHALLIS, IR
机构
[1] Safety Evaluation Department, Schering Agrochemicals Limited, Chesterford Park Research Station, Saffron Walden, Essex
关键词
D O I
10.3109/00498259109044397
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. Following oral administration of prochloraz (1-[N-propyl-N-2-(2,4,6-trichlorophenoxy)ethylcarbamoyl]imidazole) at 100 mg/kg body weight to rats, the compound underwent extensive metabolism, the primary route appearing to be opening of the imidazole ring followed by hydrolysis of the alkyl chain. The major metabolites were 2,4,6-trichlorophenoxyacetic acid and 2-(2,4,6-trichlorophenoxy)ethanol, which is present mainly as a glucuronide conjugate. Ring hydroxylation occurred to produce several minor metabolites. No unchanged prochloraz was excreted in the urine. 2. Tissue residues 96 h after dosing were generally < 1 mg prochloraz equivalents/kg tissue. The highest residues were found in the liver (2.8-5.1 mg prochloraz equivalents/kg tissue) and kidney (1.5-2.1 mg prochloraz equivalents/kg tissue), the principal organs of metabolism and excretion. Residues in female rats were generally slightly higher than those found in males. 3. The metabolites were quantitatively excreted within 96 h, with > 50% of the dosed radioactivity being found in the 0-24 h excreta. Urinary excretion accounted for 65% dose in male and 41% in female rats, respectively.
引用
收藏
页码:1473 / 1482
页数:10
相关论文
共 16 条
  • [1] EXCRETION AND METABOLISM OF 2,4,6-TRICHLOROPHENOL-C-14 IN RATS
    BAHIG, ME
    KRAUS, A
    KLEIN, W
    [J]. CHEMOSPHERE, 1981, 10 (03) : 323 - 327
  • [2] SYSTEMIC ANTIFUNGAL POTENTIAL, SAFETY, BIOTRANSPORT AND TRANSFORMATION OF MICONAZOLE NITRATE
    BRUGMANS, J
    VANCUTSE.J
    HEYKANTS, J
    SCHUERMANS, V
    THIENPONT, D
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1972, 5 (02) : 93 - 99
  • [3] COURTNEY KD, 1970, PESTICIDES S, P277
  • [4] COMPARISON OF THE PLASMA AND URINARY METABOLITES OF [ECONAZOLE-H-3 NITRATE IN THE MONKEY AND PREGNANT AND NON-PREGNANT RAT
    GIRKIN, R
    BRODIE, RR
    MIDGLEY, I
    HAWKINS, DR
    CHASSEAUD, LF
    [J]. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1983, 8 (02) : 109 - 116
  • [5] PREPARATION AND ANTIMYCOTIC PROPERTIES OF DERIVATIVES OF 1-PHENETHYLIMIDAZOLE
    GODEFROI, EF
    HEERES, J
    VANCUTSE.J
    JANSSEN, PAJ
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1969, 12 (05) : 784 - &
  • [6] GRAHAM DJM, 1987, DRUG METAB DISPOS, V15, P565
  • [7] ECONAZOLE - REVIEW OF ITS ANTIFUNGAL ACTIVITY AND THERAPEUTIC EFFICACY
    HEEL, RC
    BROGDEN, RN
    SPEIGHT, TM
    AVERY, GS
    [J]. DRUGS, 1978, 16 (03) : 177 - 201
  • [8] TOPICAL PHARMACOLOGY OF IMIDAZOLE ANTIFUNGALS
    HOLT, RJ
    [J]. JOURNAL OF CUTANEOUS PATHOLOGY, 1976, 3 (01) : 45 - 59
  • [9] COMPETITION BETWEEN SULFATION AND GLUCURONIDATION IN THE RAT INVIVO - ENZYME-KINETICS AND PHARMACOKINETICS OF CONJUGATION
    MULDER, GJ
    DAWSON, JR
    PANG, KS
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 1984, 12 (01) : 17 - 20
  • [10] CROCONAZOLE METABOLISM IN RATS
    NAKANO, M
    TAKEUCHI, M
    KAWAHARA, S
    MIZOJIRI, K
    [J]. XENOBIOTICA, 1990, 20 (04) : 385 - 393